Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Clinical trial NCT01846663 · TERMINATED
Trial details
- NCT number
- NCT01846663
- Sponsor
- Bausch Health Americas, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-03
- Primary completion
- 2016-02-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.